To determine the efficacy of Omada for Musculoskeletal (MSK)’s care
program, Omada partnered with Activision Blizzard to conduct a
claims-based cohort study to investigate:
Is it usable by any employee or dependent experiencing MSK issues,
regardless of area of concern or where they are in their care journey?
Can Omada change care pathways to remove avoidable care (imaging,
injections, Rx, and surgery) while reducing overall MSK costs?
Do members love the service, rate it as easier to use than traditional
care, and experience the same or better outcomes?